| Plant-derived vaccines: An approach for affordable vaccines against cervical cancer. | |
| | |
MedLine Citation:
|
PMID: 22327500 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Several types of human papillomavirus (HPV) are causatively associated with cervical cancer, which is the second most common cancer in women worldwide. HPV-16 and 18 are among the high risk types and responsible for HPV infection in more than 70% of the cases. The majority of cervical cancer cases occur in developing countries. Currently available HPV vaccines are expensive and probably unaffordable for most women in low and middle income countries. Therefore, there is a need to develop cost-effective vaccines for these countries. Due to many advantages, plants offer an attractive platform for the development of affordable vaccines. These include low cost of production, scalability, low health risks and the potential ability to be used as unprocessed or partially processed material. Among several techniques, chloroplast transformation is of eminent interest for the production of vaccines because of high yield of foreign protein and lack of transgene transmission through pollen. In this commentary, we focus on the most relevant aspects of plant-derived vaccines that are decisive for the future development of cost-effective HPV vaccines. |
| | |
Authors:
|
Mohammad Tahir Waheed; Johanna Gottschamel; Syed Waqas Hassan; Andreas Günter Lössl |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-01 |
Journal Detail:
|
Title: Human vaccines & immunotherapeutics Volume: 8 ISSN: 2164-554X ISO Abbreviation: Hum Vaccin Immunother Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-2-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101572652 Medline TA: Hum Vaccin Immunother Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Applied Plant Sciences and Applied Plant Biotechnology; University of Natural Resources and Applied Life Sciences (BOKU); Vienna, Austria. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Seventeen-year antibody persistence in adults primed with two doses of an inactivated hepatitis A va...
Next Document: Effective influenza vaccines for children: A critical unmet medical need and a public health priorit...